Acute Myeloid Leukemia, Not Otherwise Specified

Acute Myeloid Leukemia, Not Otherwise Specified — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02530619	Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia	unknown	N/A	26	Northwestern UniversityOTHER	1	May 26, 2021	clinicaltrials
NCT02944162	CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML	unknown	Phase 1 / Phase 2	10	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Dec 6, 2016	clinicaltrials